We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Intelerad

Intelerad Medical Systems offers medical imaging PACS and cross-enterprise workflow solutions for imaging providers r... read more Featured Products: More products

Download Mobile App




Intelerad Acquires PenRad to Expand Breast Imaging and Lung Screening Capabilities

By MedImaging International staff writers
Posted on 25 Aug 2022
Print article
Image: PenRad’s acquisition will expand Intelerad’s product offerings for mammography and lung analytics (Photo courtesy of Intelerad)
Image: PenRad’s acquisition will expand Intelerad’s product offerings for mammography and lung analytics (Photo courtesy of Intelerad)

Intelerad Medical Systems (Raleigh, NC, USA), a leading global provider of enterprise medical imaging solutions, has acquired PenRad Technologies, Inc. (Buffalo, MN, USA), a software provider for enhancing productivity for breast imaging and lung screening. The acquisition will expand Intelerad’s product offerings for mammography and lung analytics, optimizing workflows for radiologists and boosting health outcomes for patients.

The mammography market is expected to increase by more than 20% in the next several years, while the lung cancer diagnostics market is expected to reach USD 3.4 billion by 2026. Cancer screenings, and most notably, mammograms, drastically decreased during the COVID-19 pandemic as many healthcare facilities were temporarily closed and others faced severe staffing shortages. As the demand for scans continues to rise to pre-pandemic levels, innovative tools and technologies are critical to ensuring providers can meet the influx of patients, and that such screenings and scans are readily available to further improve overall health outcomes.

PenRad’s three core product offerings – PenRad for breast imaging, PenLung for lung screening, and PenTrac for patient tracking and reporting – have a proven track record of eliminating overhead costs, decreasing liability exposure and increasing patient satisfaction for innovative enterprise systems and diagnostic imaging centers and facilities. With the company’s next-generation technology and dedicated client support, PenRad is leading the way in automated diagnostic radiology. As global demand for scalable imaging and workflow solutions continues to increase, Intelerad will continue to fulfill its mission of providing clients with one of the most scalable imaging platforms in the world, enabling them to drive clinical efficiency and focus on providing enhanced patient care.

“Cancer affects all of us, whether you’ve personally been diagnosed or have witnessed a family member, friend or loved one suffer from the disease. PenRad was founded to help drive actionable change for not only my own family's breast cancer, but for millions of other individuals,” said Greg Gustafson, Founder and President of PenRad. “As our company heads into this next chapter, I’m excited to partner with Intelerad to further grow, scale, and impact patient lives and the healthcare industry at large.”

“The acquisition of PenRad is an exciting milestone for Intelerad. Our global team of dreamers and doers are committed to improving healthcare through innovative technology, which means delivering the best-in-class systems our industry needs to improve the overall health of all populations,” said Mike Lipps, CEO, Intelerad. “Lung and breast cancer impact millions of individuals, and screenings play a major role in saving lives. By integrating PenRad’s core solutions into our company, we can ensure all patients have access to the scans they need to decrease health risks, while at the same time offering healthcare systems greater productivity.”

 

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Endoscopic Ultrasound Fine Needle Biopsy Device
Acquire
New
Imaging Table
CFPM201
New
Racks
Transducer Storage Racks and Stabilizers

Print article
Radcal

Channels

MRI

view channel
Image: MRI-linac allows clinicians to see what’s going on in the brain for the first time (Photo courtesy of Sylvester Comprehensive Cancer Center)

MRI Provides Early Warning System for Glioblastoma Growth

A new study has demonstrated the potential of combining imaging with radiation to shape glioblastoma treatment in real time. The research is the first to quantify tumor changes in glioblastoma patients... Read more

Ultrasound

view channel
Image: Disease captured by the hand-held 3D photoacoustic scanner (Photo courtesy of Dr. Nam Huynh)

Medical Imaging Breakthrough to Revolutionize Cancer and Arthritis Diagnosis

Photoacoustic tomography (PAT) imaging uses laser-generated ultrasound waves to detect subtle changes in small veins and arteries, typically less than a millimeter in size and up to 15mm deep in human tissues.... Read more

Nuclear Medicine

view channel
Image: A new biomarker makes it easier to distinguish between Alzheimer’s and primary tauopathy (Photo courtesy of Shutterstock)

Diagnostic Algorithm Distinguishes Between Alzheimer’s and Primary Tauopathy Using PET Scans

Patients often present at university hospitals with diseases so rare and specific that they are scarcely recognized by physicians in private practice. Primary 4-repeat tauopathies are a notable example.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.